Quarterly report pursuant to Section 13 or 15(d)

Equity Incentive Plan Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity (Details)

v3.20.1
Equity Incentive Plan Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]    
Number of nonvested restricted common shares outstanding at beginning of period (in shares) 1,062,901 1,593,701
Weighted average grant date fair value of nonvested restricted common shares outstanding at beginning of period (in usd per share) $ 16.14 $ 15.81
Number of restricted common shares granted during period under equity incentive plan (in shares) 686,770 455,174
Weighted average grant date fair value of restricted common shares granted during period under equity incentive plan (in usd per share) $ 15.23 $ 14.40
Number of restricted common shares vested during period (in shares) (501,403) (770,385)
Weighted average grant date fair value of restricted common shares vested during period (in usd per share) $ (15.20) $ (14.50)
Number of restricted common shares forfeited during period (in shares) (5,456) (91,821)
Weighted average grant date fair value of restricted common shares forfeited during period (in usd per share) $ (14.97) $ (15.61)
Number of nonvested restricted common shares outstanding at end of period (in shares) 1,242,812 1,186,669
Weighted average grant date fair value of nonvested restricted common shares outstanding at end of period (in usd per share) $ 16.02 $ 16.14
Compensation costs related to restricted common stock $ 2.3 $ 1.9